ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

BCT BriaCell Therapeutics Corp

3,04
-0,01 (-0,33%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
BriaCell Therapeutics Corp BCT Toronto Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,01 -0,33% 3,04 22:00:16
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,05 3,04 3,05 3,04 3,05
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202414:00GLOBEBriaCell Announces Oral and Poster Presentations at ASCO..
10/4/202414:00GLOBEBriaCell 2024 AACR Preclinical Poster Confirms Strong..
09/4/202414:00GLOBEBriaCell Showcases Data Demonstrating Unmatched..
07/3/202414:00GLOBEBriaCell Receives and Executes Letter of Intent to Advance..
06/3/202414:00GLOBEBriaCell to Present Clinical Data in Central Nervous System..
27/2/202414:00GLOBEBriaCell Provides Update on Alleged Illegal Trading of..
07/2/202414:00GLOBEBriaCell Announces Strong Clinical Data in Breast Cancer..
06/2/202414:30GLOBEBreaking Ground in Prostate Cancer: BriaCell Announces Lead..
31/1/202404:48GLOBEBriaCell Therapeutics Corp. Announces Results of Shareholder..
04/1/202414:45GLOBEBriaCell Images Confirm Robust Anti-Tumor Activity in..
28/12/202314:55GLOBEBriaCell Reports 71% Central Nervous System Response Rate in..
20/12/202314:40GLOBEBriaCell Reports Unprecedented Preliminary Survival and..
06/12/202315:31GLOBEBriaCell Highlights Outstanding Topline Survival and..
06/12/202315:00GLOBEBriaCell 2023 SABCS Posters Confirm Activation of..
30/11/202313:00GLOBEBriaCell Records New Responder with Remarkable Improvement..
03/11/202313:31GLOBEBriaCell Reports Unprecedented Anti-Tumor Activity of its..
25/10/202315:15GLOBEBriaCell Forms Medical Advisory Board of Distinguished..
20/10/202315:15GLOBEOctober is Breast Cancer Awareness Month – BriaCell is..
18/10/202315:00GLOBEBriaCell Announces Presentations at the 2023 Society for the..
11/10/202315:10GLOBEBriaCell To Host Virtual Key Opinion Leader Event on..
04/10/202315:00GLOBEBriaCell Partners with New York Cancer & Blood Specialists..
03/10/202315:00GLOBEBriaCell Initiates Pivotal Phase 3 Study of Bria-IMT™ in..
08/9/202313:00GLOBEBriaCell Reports Benchmark-Beating Patient Survival and..
31/8/202317:54GLOBEBriaCell Therapeutics Corp. Announces Closing of Plan of..
31/8/202314:21GLOBEBriaCell Accepts Letter of Intent from Weill Cornell..
25/8/202320:33GLOBEBriaCell Receives Court Approval for the Share Arrangement..
18/8/202318:21GLOBEBriaCell Therapeutics Corp. Announces Voting Results From..
16/8/202314:36GLOBEBriaCell Awarded National Cancer Institute Grant to Advance..
27/6/202315:37APSNews Brief: BriaCell Therapeutics Corp.
27/6/202314:05GLOBEFDA Approves BriaCell’s Pivotal Registrational Study Design..
25/5/202315:00GLOBEBriaCell Enters Definitive Arrangement Agreement for the..
19/5/202317:38GLOBEBriaCell Closes $4 Million Strategic Investment by Prevail..
15/5/202314:00GLOBEBriaCell Announces $4 Million Strategic Investment and..

Dernières Valeurs Consultées

Delayed Upgrade Clock